New rules regarding medicine leaflets must be observed by the pharmaceutical industry starting in February

On February 6, 2024, the regulation of the National Health Surveillance Agency (“Anvisa”), RDC No 831/2023, which amends RDC No 47/2009, will come into effect. Both RDC 831/2023 and RDC 47/2009 establish the rules for the preparation, harmonization, updating, publication, and availability of medicine leaflets for patients and healthcare professionals. The regulations also define the requirements for content, format, language, and presentation of the leaflets, as well as the deadlines and procedures for their updating and availability.

INCRA opposes the transfer of control of Eldorado Brasil Celulose S.A

At the end of 2023, the National Institute of Colonization and Agrarian Reform (INCRA) notified the São Paulo Commercial Board (JUCESP) and the Securities and Exchange Commission (CVM) about the impossibility of selling the controlling interest of Eldorado Brasil Celulose S.A. (Eldorado) to C.A. Investment Brasil S.A. (CA Investment), due to the lack of prior authorization from the National Congress, as stipulated in the applicable legislation.

CADE’s Tribunal: Reestablishment of Quorum and main effects

On December 27, 2023, and shortly after his nomination was published in the Brazilian Official Journal , Diogo Thomson de Andrade took office as a commissioner of the Administrative Council for Economic Defense (“CADE”) for a four-year term. As a result, the minimum quorum of four commissioners for the functioning of the Tribunal has been reestablished.

ANPD releases Public Consultation on the role of the Data Protection Officer

The National Data Protection Authority releases a proposal for a Regulation on the role of the Data Protection Officer, defining issues such as their technical qualifications, the requirement to publish their identity, prohibition of conflicts of interest and the possibility of having multiple Data Protection Officers..

Contact
Press & Media inquiries
Marilia
(+55) 11 99617 2133
Anderson
(+55) 51 99539 1212